Found 8 matching trials
3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants
PHASE2The background of the present clinical trial is the overall aim of the Worl...
Location
Hospital Maternidad Nuestra de la Altagracia
Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months
PHASE3This is a phase III assessing the safety and immunogenicity of adjuvanted t...
3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents
PHASE1The background of the clinical trial is the overall aim of the World Health...
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months
PHASE3The trial is a phase III, non-inferiority, observer-blind, randomised, cont...
Location
5 sites in Philippines
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age
PHASE3The trial is a phase III, non-inferiority, observer-blind, randomised, acti...
Influence of BCG on TDaP-IPV Vaccination
PHASE4This study has three purposes:
To investigate whether the immune response ...
Single Session Intervention to Promote Hope
NAThe purpose of this study is to develop a brief, self-guided single-session...
Location
The Consultation Center at Yale
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
PHASE2The purpose of this study is to show that the immunogenicity of newly formu...
Location
GSK Investigational Site